ImageneBio (IMA) EPS (Weighted Average and Diluted) (2021 - 2025)
ImageneBio's (IMA) quarterly EPS (Weighted Average and Diluted) came in at -$2.91 in Q3 2025, down 12.79% year-on-year from -$3.34 in Q3 2024, and down 4750.0% quarter-over-quarter from -$0.06 in Q2 2025.
ImageneBio (IMA) EPS (Weighted Average and Diluted) (2021 - 2025) Analysis & Trends
ImageneBio has disclosed EPS (Weighted Average and Diluted) across 5 years of filings, most recently posting -$2.91 for Q3 2025.
- EPS (Weighted Average and Diluted) for Q3 2025 came in at -$2.91, down 12.79% year-over-year; the trailing twelve-month figure through Sep 2025 was $11.35 (up 416.16% YoY), and the FY2024 annual result was -$1.02, up 37.42% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$2.91 for Q3 2025 at ImageneBio, down from -$0.06 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $18.12 in Q4 2024 to a low of -$3.8 in Q1 2025.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.4 (2021), against an average of $0.22.
- Across the five-year window, EPS (Weighted Average and Diluted) jumped 4630.0% in 2024 and slumped 1051.52% in 2025, its largest moves.
- ImageneBio's EPS (Weighted Average and Diluted) stood at $0.1 in 2021, then sank by 490.19% to -$0.39 in 2022, then declined by 2.56% to -$0.4 in 2023, then surged by 4630.0% to $18.12 in 2024, then sank by 116.06% to -$2.91 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$2.91 (Q3 2025), -$0.06 (Q2 2025), and -$3.8 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | ImageneBio | 3.18 Mn | 3.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.91 |
| Jun 30, 2025 | -0.06 |
| Mar 31, 2025 | -3.80 |
| Dec 31, 2024 | 18.12 |
| Sep 30, 2024 | -2.58 |
| Jun 30, 2024 | -0.28 |
| Mar 31, 2024 | -0.33 |
| Dec 31, 2023 | -0.40 |
| Sep 30, 2023 | -0.40 |
| Jun 30, 2023 | -0.44 |
| Mar 31, 2023 | -0.39 |
| Dec 31, 2022 | -0.39 |
| Sep 30, 2022 | -0.48 |
| Jun 30, 2022 | -0.57 |
| Mar 31, 2022 | -0.47 |
| Dec 31, 2021 | 0.10 |
| Sep 30, 2021 | -0.40 |
| Jun 30, 2021 | -0.35 |